The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Adil Agarwal
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by Dr. Adil Agarwal, who is part of the promoter group of Dr. Agarwals Health Care Ltd. Regulation 29(2) requires promoters or persons acting in concert to disclose acquisitions or disposals crossing the 2% shareholding threshold in a financial year. The specific direction (buy or sell) and exact quantum of shares transacted are not mentioned in the headline. Investors should check the detailed disclosure on BSE/NSE to know whether this is an increase or decrease in promoter holding.
As this is a promoter-level disclosure related to stake movement, it may signal a change in promoter shareholding, which shareholders should track for shifts in ownership pattern.